Neuro-Oncology Reviews
Volume
26 Number 10
31 May 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 10, 31 May
Cuccia F, Jafari F, D'Alessandro S, Carruba G, Craparo G, Tringali
G, Blasi L, Ferrera G.
Preferred
Imaging for Target Volume Delineation for Radiotherapy of
Recurrent Glioblastoma: A Literature Review of the Available
Evidence.
J
Pers Med. 2024 May 17;14(5):538. doi:
10.3390/jpm14050538. PMID:
38793120. Review. ˍ
Indira Chandran V, Gopala S, Venkat EH, Kjolby M, Nejsum P.
Extracellular vesicles in
glioblastoma: a challenge and an opportunity.
NPJ
Precis Oncol. 2024 May 17;8(1):103. doi:
10.1038/s41698-024-00600-2. PMID:
38760427. Review. ˍ
Rudà R, Horbinski C, van den Bent M, Preusser M, Soffietti
R.
IDH inhibition in gliomas: from
preclinical models to clinical trials.
Nat
Rev Neurol. 2024 May 17. doi:
10.1038/s41582-024-00967-7. PMID:
38760442. Review. ˍ
Smith CJ, Perfetti TA, Chokshi C, Venugopal C, Ashford JW, Singh
SK.
Alkylating agents are possible
inducers of glioblastoma and other brain tumors.
Hum
Exp Toxicol. 2024 May 17;43:9603271241256598. doi:
10.1177/09603271241256598. PMID:
38758727. Review. ˍ
Aboulhosn R, Bodkin P.
Bilateral
tinnitus associated with a diffuse astrocytoma of Heschl's gyrus:
a case report and review of literature.
J
Surg Case Rep. 2024 May 18;2024(5):rjae317. doi:
10.1093/jscr/rjae317. PMID:
38764736. Case report; Review. ˍ
Auricchio AM, Pennisi G, Menna G, Olivi A, Gessi M, Gielen GH,
Gaudino S, Montano N, Papacci F.
H3K27-Altered
Diffuse Glioma of the Spinal Cord in Adult Patients: A Qualitative
Systematic Review and Peculiarity of Radiological Findings.
J
Clin Med. 2024 May 18;13(10):2972. doi:
10.3390/jcm13102972. PMID:
38792513. Case report; Review. ˍ
Bennett J, Yeo KK, Tabori U, Hawkins C, Lim-Fat MJ.
Pediatric-type low-grade gliomas in
adolescents and young adults-challenges and emerging paradigms.
Childs
Nerv Syst. 2024 May 18. doi:
10.1007/s00381-024-06449-x. PMID:
38761264. Review˰ ˍ
*Romano A, De Giorgi S, Romano A, Moltoni G, Ascolese AM,
Stoppacciaro A, Bozzao A.
"Vanishing"
glioblastoma: A case report and review of the literature.
Radiol
Case Rep. 2024 May 18;19(8):3276-3282. doi:
10.1016/j.radcr.2024.04.040. PMID:
38812592. Case report; Review. ˍ
Al-Rahbi A, Al-Mahrouqi O, Al-Saadi T.
Uses
of artificial intelligence in glioma: A systematic review.
Med
Int (Lond). 2024 May 20;4(4):40. doi:
10.3892/mi.2024.164. PMID:
38827949.
Review. ˍ
Arms LM, Duchatel RJ, Jackson ER, Sobrinho PG, Dun MD, Hua
S.
Current status and advances to
improving drug delivery in diffuse intrinsic pontine glioma.
J
Control Release. 2024 May 20:S0168-3659(24)00302-X.
doi:
10.1016/j.jconrel.2024.05.018. PMID:
38744345. Review. ˍ
Han PC, Baker TG.
Glial and
glioneuronal tumors: Navigating the complexity of evolving
concepts and new classification.
J
Neurol Sci. 2024 May 20;461:123058. doi:
10.1016/j.jns.2024.123058. PMID:
38781807. Review˰ ˍ
Azimi P, Yazdanian T, Ahmadiani A.
mRNA
markers for survival prediction in glioblastoma multiforme
patients: a systematic review with bioinformatic analyses.
BMC
Cancer. 2024 May 21;24(1):612. doi:
10.1186/s12885-024-12345-z. PMID:
38773447. Review. ˍ
Piper K, Kumar JI, Domino J, Tuchek C, Vogelbaum MA.
Consensus
Review on Strategies to Improve Delivery Across the BBB Including
Focused Ultrasound.
Neuro
Oncol. 2024 May 21:noae087. doi:
10.1093/neuonc/noae087. PMID:
38770775. Review. ˍ
van der Meulen M, Wijnenga MMJ.
Education
and training in neurology: developments and future challenges.
Eur
J Neurol. 2024 May 21:e16332. doi:
10.1111/ene.16332. PMID:
38773718. Review. ˍ
Wu H, Zhou F, Gao W, Chen P, Wei Y, Wang F, Zhao H.
Current
status and research progress of minimally invasive treatment of
glioma.
Front
Oncol. 2024 May 21;14:1383958. doi:
10.3389/fonc.2024.1383958. PMID:
38835394. Review.
ˍ
Bansal I, Merchant TE.
Radiotherapy
for pediatric low-grade glioma.
Childs
Nerv Syst. 2024 May 22. doi:
10.1007/s00381-024-06460-2. PMID:
38775957. Review˰ ˍ
Nusraty S, Boddeti U, Zaghloul KA, Brown DA.
Microglia
in Glioblastomas: Molecular Insight and Immunotherapeutic
Potential.
Cancers
(Basel). 2024 May 22;16(11):1972. doi:
10.3390/cancers16111972. PMID:
38893093.
Review. ˍ
Castellano-Damaso
S, Vazquez-Gomez F, Moreno-Carrasco JL, Arce B, Borrego P,
Lassaletta A.
Continuous
response despite reduced dose of trametinib as single agent in an
adolescent with a relapsed disseminated pediatric low-grade glioma
KIAA1549-BRAF
fusion
positive: a case report and review of the literature.
Front
Oncol.
2024 May 23;14:1381354. doi:
10.3389/fonc.2024.1381354. PMID:
38846974. Case report; Review. ˍ
Shah S, Mansour HM, Aguilar TM, Lucke-Wold B.
Advances
in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic
Supplemental Treatment for Glioblastoma.
Int
J Mol Sci. 2024 May 23;25(11):5694. doi:
10.3390/ijms25115694. PMID:
38891882.
Review. ˍ
Turkistani AN, Alsharif TH, Aldhafeeri WF, Aljohani S, Alomar S.
Medical management for cerebellar
mutism syndrome following posterior fossa surgery: A systematic
review.
Clin
Neurol Neurosurg. 2024 May 23;242:108352. doi:
10.1016/j.clineuro.2024.108352. PMID:
38823197. Review.
˰
*Zhang R, Li X, Zhang S.
The Role of
Bacteria in Central Nervous System Tumors: Opportunities and
Challenges.
Microorganisms.
2024 May 23;12(6):1053. doi:
10.3390/microorganisms12061053. PMID:
38930435.
Review. ˍ
Alorfi NM, Ashour AM, Alharbi AS, Alshehri FS.
Targeting
inflammation in glioblastoma: An updated review from
pathophysiology to novel therapeutic approaches.
Medicine
(Baltimore). 2024 May 24;103(21):e38245. doi:
10.1097/MD.0000000000038245. PMID:
38788009. Review. ˍ
Baticulon RE, Wittayanakorn N, Maixner W.
Low-grade
glioma of the temporal lobe and tumor-related epilepsy in
children.
Childs
Nerv Syst. 2024 May 24. doi:
10.1007/s00381-024-06468-8. PMID:
38789690. Review. ˍ
Gupta T, Mani S, Chatterjee A, Dasgupta A, Epari S, Chinnaswamy G.
Risk-stratification for treatment
de-intensification in WNT-pathway medulloblastoma: finding the
optimal balance between survival and quality of survivorship.
Expert
Rev Anticancer Ther. 2024 May 24:1-10. doi:
10.1080/14737140.2024.2357807. PMID:
38761170. Review˰ ˍ
Bajin IY, Levine A, Dewan MC, Bennett J, Tabori U, Hawkins C,
Bouffet E.
Understanding diffuse
leptomeningeal glioneuronal tumors.
Childs
Nerv Syst. 2024 May 25. doi:
10.1007/s00381-024-06432-6. PMID:
38795167. Review˰ ˍ
Sachani P, Dhande R, Parihar P, Saifi I, Kasat PR.
Central
Neurocytoma: A Case Report With Literature Review.
Cureus.
2024 May 24;16(5):e60969. doi:
10.7759/cureus.60969. PMID:
38915980. Case report; Review. ˍ
Smerdi D, Moutafi M, Kotsantis I,
Stavrinou LC, Psyrri A.
Overcoming
Resistance to Temozolomide in Glioblastoma: A Scoping Review of
Preclinical and Clinical Data.
Life
(Basel). 2024 May 24;14(6):673.
doi:
10.3390/life14060673. PMID:
38929657.
Review. ˍ
Iqbal
MS, Belal Bin Heyat M, Parveen S, Ammar Bin Hayat M, Roshanzamir
M, Alizadehsani R, Akhtar F, Sayeed E, Hussain S, Hussein HS,
Sawan M.
Progress
and trends in neurological disorders research based on deep
learning.
Comput
Med Imaging Graph.
2024 May 25;116:102400. doi:
10.1016/j.compmedimag.2024.102400. PMID:
38851079. Review˰ ˍ
*Wei J, Wang M, Li S, Han R, Xu W, Zhao A, Yu Q, Li H, Li M, Chi
G.
Reprogramming of astrocytes and
glioma cells into neurons for central nervous system repair and
glioblastoma therapy.
Biomed
Pharmacother. 2024 May 25;176:116806. doi:
10.1016/j.biopha.2024.116806. PMID:
38796971. Review. ˍ
Agosti
E, Zeppieri M, Ghidoni M, Ius T, Tel A, Fontanella MM, Panciani
PP.
Role
of glioma stem cells in promoting tumor chemo- and
radioresistance: A systematic review of potential targeted
treatments.
World
J Stem Cells.
2024 May 26;16(5):604-614. doi:
10.4252/wjsc.v16.i5.604. PMID:
38817336. Review. ˍ
Mousavikia SN, Darvish L, Bahreyni Toossi MT, Azimian H.
Exosomes: Their role in the diagnosis,
progression, metastasis, and treatment of glioblastoma.
Life
Sci. 2024 May 26;350:122743. doi:
10.1016/j.lfs.2024.122743. PMID:
38806071. Review˰ ˍ
Ser
MH, Webb M, Thomsen A, Sener U.
Isocitrate
Dehydrogenase Inhibitors in Glioma: From Bench to Bedside.
Pharmaceuticals
(Basel).
2024 May 26;17(6):682. doi:
10.3390/ph17060682. PMID:
38931350.
Review. ˍ
Sadowski K, Jażdżewska A, Kozłowski J, Zacny A,
Lorenc T, Olejarz W.
Revolutionizing
Glioblastoma Treatment: A Comprehensive Overview of Modern
Therapeutic Approaches.
Int
J Mol Sci. 2024 May 26;25(11):5774. doi:
10.3390/ijms25115774. PMID:
38891962.
Review. ˍ
Azab MA.
An Adult Case of
Medulloblastoma with Multiple Lung Metastatic Lesions-Case Report
and Literature Review.
Asian
J Neurosurg. 2024 May 27;19(2):286-289. doi:
10.1055/s-0044-1787080. PMID:
38974448. Case
report; Review. ˍ
Nichols
NM, Ezzat B, Waters AC, Panov F, Yong RL, Germano IM.
What
is the cognitive footprint of insular glioma?
Front
Hum Neurosci.
2024 May 27;18:1382380. doi:
10.3389/fnhum.2024.1382380. PMID:
38859993. Review. ˍ
Gregucci F, Beal K, Knisely JPS, Pagnini P, Fiorentino A, Bonzano
E, Vanpouille-Box CI, Cisse B, Pannullo SC, Stieg PE, Formenti SC.
Biological Insights and
Radiation-Immuno-Oncology Developments in Primary and Secondary
Brain Tumors.
Cancers
(Basel). 2024 May 28;16(11):2047. doi:
10.3390/cancers16112047. PMID:
38893165.
Review. ˍ
Mokhtarpour K, Akbarzadehmoallemkolaei M, Rezaei N.
A
viral attack on brain tumors: the potential of oncolytic virus
therapy.
J
Neurovirol. 2024 May 28. doi:
10.1007/s13365-024-01209-8. PMID:
38806994. Review˰ ˍ
Faisal SM, Ravi VM, Miska JM.
Editorial:
Spatiotemporal heterogeneity in CNS tumors.
Front
Immunol. 2024 May 29;15:1430227. doi:
10.3389/fimmu.2024.1430227. PMID:
38868775. Editorial. ˍ
Galbraith K, Snuderl M.
Molecular
Pathology of Gliomas.
Clin
Lab Med. 2024 May 29;44(2):149-159. doi:
10.1016/j.cll.2023.08.009. PMID:
38821638. Review˰
ˍ
Harrak
M, Kamal S, Zerbani H, El Bakouri H, Ouaya S, Sellal N, El Hfid M.
Cervical
Lymph Node Metastasis From Medulloblastoma in a Young Adult: Case
Report and Literature Review.
Cureus.
2024 May 29;16(5):e61339. doi:
10.7759/cureus.61339. PMID:
38947611. Case report; Review. ˍ
Read RD, Tapp ZM, Rajappa P, Hambardzumyan D.
Glioblastoma
microenvironment-from biology to therapy.
Genes
Dev. 2024 May 29. doi:
10.1101/gad.351427.123. PMID:
38811170. Review˰ ˍ
Slack JC, Church AJ.
Molecular
Alterations in Pediatric Solid Tumors.
Clin
Lab Med. 2024 May 29;44(2):277-304. doi:
10.1016/j.cll.2023.08.012. PMID:
38821645. Review˰
ˍ
Begagić
E, Bečulić H, Džidić-Krivić A, Kadić
Vukas S, Hadžić S, Mekić-Abazović A, Šegalo
S, Papić E, Muchai Echengi E, Pugonja R, Kasapović T,
Kavgić D, Nuhović A, Juković-Bihorac F, Đuričić
S, Pojskić M.
Understanding
the Significance of Hypoxia-Inducible Factors (HIFs) in
Glioblastoma: A Systematic Review.
Cancers
(Basel).
2024 May 30;16(11):2089. doi:
10.3390/cancers16112089. PMID:
38893207.
Review. ˍ
Navasardyan I, Zaravinos A, Bonavida B.
Therapeutic
Implications of Targeting YY1 in Glioblastoma.
Cancers
(Basel). 2024 May 30;16(11):2074. doi:
10.3390/cancers16112074. PMID:
38893192.
Review. ˍ
Wu Q, Berglund AE, Macaulay RJ, Etame AB.
The
Role of Mesenchymal Reprogramming in Malignant Clonal Evolution
and Intra-Tumoral Heterogeneity in Glioblastoma.
Cells.
2024 May 30;13(11):942. doi:
10.3390/cells13110942. PMID:
38891074.
Review. ˍ
*Yabo YA, Heiland DH.
Understanding
glioblastoma at the single-cell level: Recent advances and future
challenges.
PLoS
Biol. 2024 May 30;22(5):e3002640. doi:
10.1371/journal.pbio.3002640. PMID:
38814900. Review. ˍ
Zahid
A, Hammoud Z, Farhat S, Kaiwan O, Al-Inaya Y, Cortiana V, Pahwa B,
Chopra H, Parmar M, Kamal MA, Sethi Y.
The
Potential of Nano Pharmaceuticals to Change the Paradigm of Brain
Tumor Therapy: A State-of-the-Art Review.
Curr
Cancer Drug Targets.
2024 May 30. doi:
10.2174/0115680096286740240507092553. PMID:
38818905. Review˰ ˍ
Golan H, Tursunov KK, Volkov O.
Systematic
Review of the First 40 Cases of 177Lu-PSMA
Therapy in the Treatment of Non-prostatic Cancer.
Anticancer
Res. 2024 May 31;44(6):2297-2305. doi:
10.21873/anticanres.17037. PMID:
38821587. Review.
ˍ
Lassaletta A, Zapotocky M, Bouffet E.
Chemotherapy
in pediatric low-grade gliomas (PLGG).
Childs
Nerv Syst. 2024 May 31. doi:
10.1007/s00381-024-06458-w. PMID:
38819670. Review˰ ˍ
Malmberg
C, Hellquist BN, Sadanandan SA, Sandström M, Wu WY, Björkblom
B, Melin B, Sjöberg RL.
Antidepressant
drugs and risk of developing glioma: a national registry-based
case control study and a meta-analysis.
Am
J Epidemiol.
2024 May 31:kwae100. doi:
10.1093/aje/kwae100. PMID:
38825331. Observational study; Meta-analysis.
ˍ